All posts tagged
The UK Steps Up its Game in Automated CRISPR Gene Editing
Europe’s Lag in the Gene Editing Race may leave its Biotech Obsolete
‘Packaged’ CRISPR Systems to Standardize novel Biomedical Research
10 Hot European Biotechs to Observe in 2017 🚀
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
These are our 10 Most Read Biotech Articles of 2016
Stories We Didn’t Cover: Next Human CRISPR Trials by Intellia?
Our Startup Battle Winner uses CRISPR in a Whole New Way
UPDATE: No Clear Winner in the CRISPR Patent Battle
Evotec gets hold of CRISPR in a new Partnership with Merck
CRISPR meets RNAi: a whole new Targeted Therapy
How much of a Gamble is Investing in CRISPR?
Labiotech UG, All Rights Reserved -
Send this to friend